Добірка наукової літератури з теми "Treatment responder"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Treatment responder".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Treatment responder"

1

Lee, Seo-Ho, Dennis M. Bonal, Diana Olguta Treaba, et al. "Sry-Box Transcription Factor 9 (SOX9)-Driven Mesenchymal Stromal Cell Differentiation Signature As a Determinant of Induction Chemotherapy Responsiveness in Acute Myeloid Leukemia Core Bone Marrow Biopsies." Blood 142, Supplement 1 (2023): 4299. http://dx.doi.org/10.1182/blood-2023-189679.

Повний текст джерела
Анотація:
Leukemic clones in acute myeloid leukemia (AML) alter the bone marrow (BM) microenvironment so that the normal functions of hematopoietic stem cells (HSCs) are interrupted, aiding malignant progression. Accumulating evidence points to a protective role that the microenvironment provides for the AML clone (Colmone et al., Science, 2008). It is therefore crucial to detail the mechanisms by which the BM stroma promotes leukemia progression to inform the development of more effective targeted therapies. Most studies focused on detailing the role of BM stroma in AML etiology use BM aspirates, which
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Barrow, Rhiannon, James A. Poulter, Martina A. Finetti, Erica Wilson, Colin A. Johnson, and Lucy Stead. "Modulation of GABA Neurotransmitter Signalling Impacts Glioblastoma Spheroid Growth and Response to Standard Treatment." Neuro-Oncology 24, Supplement_4 (2022): iv3—iv4. http://dx.doi.org/10.1093/neuonc/noac200.013.

Повний текст джерела
Анотація:
Abstract AIMS We have identified two subtypes within glioblastoma (GBM), defined by whether a specific subset of genes is upregulated (Up responders) or downregulated (Down responders) in response the standard treatment. The biology of therapy-driven transcriptional reprogramming in the two subtypes suggests the differential involvement of GABA neurotransmitter signalling in the underlying treatment resistance mechanisms. Our aim was to address our hypothesis that modulating GABA signalling will impact treatment response in GBM, in different ways for different responder subtypes. METHOD We ide
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Vancappel, Alexis, Yecodji Dansou, Ophelia Godin, et al. "Evolution of Cognitive Impairments in Treatment-Resistant Depression: Results from the Longitudinal French Centers of Expertise for Treatment-Resistant Depression (FACE-DR) Cohort." Brain Sciences 13, no. 7 (2023): 1120. http://dx.doi.org/10.3390/brainsci13071120.

Повний текст джерела
Анотація:
Previous studies set out profound cognitive impairments in subjects with treatment-resistant depression (TRD). However, little is known about the course of such alterations depending on levels of improvement in those patients followed longitudinally. The main objective of this study was to describe the course of cognitive impairments in responder versus non-responder TRD patients at one-year follow-up. The second aim was to evaluate the predictive aspect of cognitive impairments to treatment resistance in patients suffering from TRD. We included 131 patients from a longitudinal cohort (FACE-DR
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Treaba, Diana O., Dennis M. Bonal, Anna D. Chorzalska, et al. "Levels of Osteopontin (SPP1), Osteonectin (SPARC) and Biglycan (BGN) in Acute Myeloid Leukemia Bone Marrow Biopsies Post-Induction Therapy Define the Status of Osteogenic Niche and Show Inverse Correlation with Therapeutic Response." Blood 136, Supplement 1 (2020): 29–30. http://dx.doi.org/10.1182/blood-2020-142604.

Повний текст джерела
Анотація:
Background: Acute Myeloid Leukemia (AML) has a five-year survival rate of 25% and its high mortality is linked to poor response to treatment and relapse. Our understanding of the molecular mechanisms controlling relapse and AML progression is limited. Animal models indicate that AML cells significantly modulate their bone marrow microenvironment inducing gradual loss of endosteal and vascular niches, both playing critical roles in support and maintenance of normal hematopoiesis. The goal of this study was to determine microenvironmental factors driving the gradual retraction of endosteal and v
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Schreiber, S. W., D. B. Clemow, A. Keohane, et al. "P1071 Trajectories of response in patients with moderately-to-severely active ulcerative colitis treated with mirikizumab: Results from the LUCENT-1 study." Journal of Crohn's and Colitis 19, Supplement_1 (2025): i1978—i1979. https://doi.org/10.1093/ecco-jcc/jjae190.1245.

Повний текст джерела
Анотація:
Abstract Background Mirikizumab, an anti-IL-23p19 antibody, demonstrated robust efficacy in improving clinical and endoscopic endpoints with an acceptable safety profile1. We explored the trajectory of response to mirikizumab treatment in patients with moderate-to-severely active ulcerative colitis. Methods Mirikizumab patients described previously1 were assessed via Growth Mixture Model (GMM) to identify distinct clusters based on individual patient response trajectories. The sum of stool frequency and rectal bleeding modified Mayo subscores was used in the GMM to identify trajectories. Week
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Editorial Staff. "Genetic Polymorphisms in GABRD and Treatment Response and Dose in Methadone Maintenance Treatment." Precision Medicine Communications 1, no. 1 (2021): 05–07. http://dx.doi.org/10.55627/pmc.001.01.0073.

Повний текст джерела
Анотація:
Xie and colleagues studied the association between the genetic polymorphs of the GABA receptor delta subunit (GABARD) and dose-response to methadone in heroin addicts subjected to methadone maintenance therapy (MMT) was studied. They investigated two groups: responders and non-responders were created from a total of 286 recruited MMT patients where the parameter for classification was retention time in therapy. According to stabilized methadone dose, 177 patients were divided into subgroups of high dose and low dose. TaqMan SNP assay was used for GABRD genotyping and the following single nucle
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Sudo, Kazuki, Ken Kato, Juntaro Matsuzaki, et al. "Serum microRNAs to predict the response to nivolumab in patients with esophageal squamous cell carcinoma." Journal of Clinical Oncology 35, no. 15_suppl (2017): e14511-e14511. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e14511.

Повний текст джерела
Анотація:
e14511 Background: A phase II study demonstrated that nivolumab (Nivo), a PD-1 inhibitor, had a meaningful activity for patients with esophageal squamous cell carcinoma. Although several biomarkers, including PD-L1 expression levels in tumor tissue, are explored to predict the efficacy of Nivo, further investigation is needed. Here we evaluated whether serum levels of microRNA (miRNA) could be a candidate of predictive markers. Methods: Among 65 patients who participated in the phase II study (JapicCTINo.142422) and received Nivo 3 mg/kg IV Q2W, 19 patients were treated at our institution. Pat
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Sánchez-Sanz, Alicia, Rafael Muñoz-Viana, Julia Sabín-Muñoz, et al. "Response to Fingolimod in Multiple Sclerosis Patients Is Associated with a Differential Transcriptomic Regulation." International Journal of Molecular Sciences 25, no. 3 (2024): 1372. http://dx.doi.org/10.3390/ijms25031372.

Повний текст джерела
Анотація:
Fingolimod is an immunomodulatory sphingosine-1-phosphate (S1P) analogue approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). The identification of biomarkers of clinical responses to fingolimod is a major necessity in MS to identify optimal responders and avoid the risk of disease progression in non-responders. With this aim, we used RNA sequencing to study the transcriptomic changes induced by fingolimod in peripheral blood mononuclear cells of MS-treated patients and their association with clinical response. Samples were obtained from 10 RRMS patients (five responder
Стилі APA, Harvard, Vancouver, ISO та ін.
9

M Arif, Rana, Fahad Aman Khan, Imran Khan, Muzammil Aslam Kataria, Jawed Iqbal, and Mukhtar Ahmed. "Vitamin D Deficiency in HCV Antiviral Treatment Responders versus Non-Responders." Journal of Islamabad Medical & Dental College 8, no. 1 (2019): 45–49. http://dx.doi.org/10.35787/jimdc.v8i1.316.

Повний текст джерела
Анотація:
Background: Hepatitis C virus (HCV) is a major cause of chronic liver disease (CLD). Pakistan has a high burden of infectious diseases, including HCV. Its prevalence varies according to geographic regions in the country from about 2·4% to 6·5%. The objective of the study was to compare the frequency of vitamin D deficiency in responders and non-responders of antiviral treatment for chronic hepatitis C.Material and Methods: This comparative cross-sectional study was conducted in Hepatitis Clinic, Jinnah hospital, Lahore from 20th May to 20th November 2013. After ethical approval, participants w
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Van Hoef, M. "Interim results of a survey to evaluate use and interest in autologous and allogeneic bone marrow transplant as a treatment option among patients." Journal of Clinical Oncology 27, no. 15_suppl (2009): e17569-e17569. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e17569.

Повний текст джерела
Анотація:
e17569 Background: A survey was placed on websites inviting patients to provide an opinion about bone marrow transplant as treatment option for their disease. Herein an interim analysis of results is presented. Methods: A survey was developed requesting general information about the responder, the disease, and the experience with and interest in autologous and allogeneic donor transplants as treatment option for disease. The survey was placed on sites in the Netherlands and Belgium (cancer fora and website) and was initially announced in a few magazins. Results: Several cancer fora in the Neth
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Treatment responder"

1

Gloster, Andrew T., Rainer Sonntag, Jürgen Hoyer, et al. "Treating Treatment-Resistant Patients with Panic Disorder and Agoraphobia Using Psychotherapy: A Randomized Controlled Switching Trial." Karger, 2015. https://tud.qucosa.de/id/qucosa%3A71640.

Повний текст джерела
Анотація:
Background: Nonresponsiveness to therapy is generally acknowledged, but only a few studies have tested switching to psychotherapy. This study is one of the first to examine the malleability of treatment-resistant patients using acceptance and commitment therapy (ACT). Methods: This was a randomized controlled trial that included 43 patients diagnosed with primary panic disorder and/or agoraphobia (PD/A) with prior unsuccessful state-of-the-art treatment (mean number of previous sessions = 42.2). Patients were treated with an ACT manual administered by novice therapists and followed up for 6 mo
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Byström, Per. "Colorectal cancer treatment and early response evaluation how do we best evaluate treatment response? /." Stockholm, 2010. http://diss.kib.ki.se/2010/978-91-7409-766-5/.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Clowes, Jackie A. "The effect of dietary factors and osteoporosis treatment on bone turnover." Thesis, University of Sheffield, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.251195.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Singh, Namrata. "The Effects of Parent Training in Pivotal Response Treatment (PRT) and Continued Support through Telemedicine on Gains in Communication in Children with Autism Spectrum Disorder." Thesis, The University of Arizona, 2014. http://hdl.handle.net/10150/315907.

Повний текст джерела
Анотація:
A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment of the requirements for the Degree of Doctor of Medicine.<br>Introduction: With the increase in children diagnosed with autism spectrum disorders (ASD) each year comes the need for individualized interventions necessary for children with autism. Many of the treatments currently available are time consuming, costly, and rely heavily on behavioral interventionists despite the lack of qualified interventionists to provide these services. Therefore, there is a growing recognition of the need for ef
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Philip, Judith Mary Dundas. "Immune responses following Praziquantel treatment of schistosomiasis." Thesis, University of Cambridge, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.615292.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Matthiasson, Páll. "Dealing with treatment resistance to clozapine : characteristics of treatment response in schizophrenia." Thesis, King's College London (University of London), 2006. https://kclpure.kcl.ac.uk/portal/en/theses/dealing-with-treatment-resistance-to-clozapine--characteristics-of-treatment-response-in-schizophrenia(f43c968b-8789-44e7-9161-3cab811ee429).html.

Повний текст джерела
Анотація:
Background: Clozapine, the treatment of choice in treatment-resistant schizophrenia, is not effective in up to half of patients. Aims of this thesis were: to verify whether clozapine augmentation with amisulpride, an atypical antipsychotic with preferential affinity at doparninergic D2-like receptors, is clinically effective; to test the prediction that changes in D2-like receptor availability might explain that improvement; to explore clinical and receptor availability characteristics of good clozapine responders. Methods: Study 1: Thirty-three patients with schizophrenia, partially or non-re
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Sunkara, Sesh. "Interventions for poor responders undergoing in vitro fertilisation treatment." Thesis, King's College London (University of London), 2013. https://kclpure.kcl.ac.uk/portal/en/theses/interventions-for-poor-responders-undergoing-in-vitro-fertilisation-treatment(63a0ad08-f73f-406e-93db-7aa226d4c160).html.

Повний текст джерела
Анотація:
This thesis examines the various interventions proposed for the management of poor responders undergoing IVF treatment. I began by performing a systematic review and meta-analysis to identify the ideal controlled ovarian hyperstimulation (COH) regimen for women with poor ovarian response undergoing IVF. The systematic review found the evidence to be inconsistent and inconclusive. The poor responders intervention trial (PRINT) was thus conceived. PRINT is an RCT comparing the gonadotrophin releasing hormone (GnRH) agonist long versus the GnRH agonist short versus the GnRH antagonist regimens fo
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Weverling, Gerrit Jan. "Measuring treatment response in HIV-1 infection." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2000. http://dare.uva.nl/document/83204.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Quinn, Stephen. "Uterine fibroids : response to novel treatment modalities." Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/24737.

Повний текст джерела
Анотація:
Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive, thermal ablation treatment for uterine fibroids. There is currently limited data regarding the long-term efficacy of this method and the effect of this treatment on circulating cytokine and growth factors. In this thesis I have: 1. Presented the most accurate method of measuring fibroid volumes, and propose a new classification system for describing fibroid uteri. 2. Reviewed the characteristics of a cohort of uterine fibroid subjects and perform a longitudinal analysis of MRgFUS results. 3. Assessed the fibroid volume tr
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Ghadiri, Mahtab. "Peripheral Immune Phenotyping in Multiple Sclerosis: Immunomodulatory Treatment Effects and Treatment Response Biomarkers." Thesis, The University of Sydney, 2019. http://hdl.handle.net/2123/20809.

Повний текст джерела
Анотація:
Disease modifying therapies (DMTs) used in the treatment of relapsing remitting multiple sclerosis (RRMS) have broad effects on the immune system that are incompletely understood. There is great heterogeneity in treatment response to most DMTs. However, biomarkers predicting treatment response are lacking. In this thesis, the peripheral immune changes induced by treatment with two DMTs, fingolimod (FTY) and dimethyl fumarate (DMF), are examined in detail by immune phenotyping using multicolour flow cytometry. Chapter 3 presents a longitudinal study of T cell subsets in patients commencing tr
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Treatment responder"

1

Aehlert, Barbara. Emergency medical responder: First responder in action. 2nd ed. McGraw Hill, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

S, Mitchell Malcolm, ed. Biological approaches to cancer treatment: Biomodulation. McGraw-Hill, Health Professions Division, 1993.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

1947, Talpaz Moshe, Kurzrock Razelle, and Gutterman Jordan U, eds. Biological response modifiers in the treatment of hematopoietic neoplasia. Dekker, 1992.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

College, Cornell University Medical, and United States. Army Medical Research and Development Command, eds. Immunologic intervention in HIV infection: Anti-polymerase responses and hormonal regulation. U.S. Army Medical Research and Development Command, 1992.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Pfeifer, Patrice. Doctor, ¿es la próstata?: Un urólogo responde sin rodeos a todas sus preguntas. Hispano Europea, 2008.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Pescatore, Fred. The science of AHCC: Supplement for 21st century cancer treatment. Basic Health Publications, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Jainchill, Nancy. Understanding and treating adolescent substance use disorders: Assessment, treatment, juvenile justice responses. Civic Research Institute, 2012.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Yau, Kenneth Kwok Chi. Assessing and predicting treatment responses to cholinesterase inhibitor pharmacotherapy in Alzheimer's disease. National Library of Canada, 2000.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Division, United States Environmental Protection Agency Emissions Standards. Sewage treatment plant NSPS: Responses to comments on April 1986 proposed revisions. U.S. Environmental Protection Agency, Office of Air and Radiation, Office of Air Quality Planning and Standards, 1988.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

International Conference on Chemical Modifiers of Cancer Treatment (9th 1995 Oxford, Great Britain). Ninth International Conference on Chemical Modifiers of Cancer Treatment: Oxford, UK, 22-26 August 1995. Stockton Press, 1996.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Treatment responder"

1

Gralnik, Leonard M., and Jose A. Rey. "Psychopharmacologic Treatment of Psychiatric Disorders in First Responders." In First Responder Mental Health. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-38149-2_14.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Miller, Laurence. "Psychological Stress Syndromes and Treatment Strategies for Law Enforcement Personnel." In First Responder Mental Health. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-38149-2_1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Habr-Gama, Angelita, Maria Susana Bruzzi, Maria Laura Morici, Guilherme Pagin São Julião, and Rodrigo Oliva Perez. "The Proper Treatment for the Complete Responder After Neoadjuvant Therapy." In Surgical Techniques in Rectal Cancer. Springer Japan, 2017. http://dx.doi.org/10.1007/978-4-431-55579-7_5.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Weissman, Ariel, and Colin M. Howles. "Treatment Strategies in Assisted Reproduction for the Poor-Responder Patient." In Textbook of Assisted Reproductive Techniques, 6th ed. CRC Press, 2023. http://dx.doi.org/10.1201/9781003268611-52.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Beidel, Deborah C., Kathryn D. Sunderman, Ashley T. Winch, and Clint A. Bowers. "Virtual Reality Treatments." In First Responder Mental Health. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-38149-2_15.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Turiault, Marc, Caroline Cohen, Guy Griebel, et al. "Treatment Response." In Encyclopedia of Psychopharmacology. Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_1423.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Kalelioglu, Tuba, and Sohil H. Patel. "Treatment Response." In Hybrid PET/MR Neuroimaging. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-82367-2_50.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Nover, L. "Hyperthermic Treatment of Cancer." In Heat Shock Response. CRC Press, 2022. http://dx.doi.org/10.1201/9780367811730-25.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Lautenschlaeger, Tim, Martha Matuszak, and Feng-Ming (Spring) Kong. "Treatment response assessment and response guided adaptive treatment." In Principles and Practice of Image-Guided Radiation Therapy of Lung Cancer. CRC Press, 2017. http://dx.doi.org/10.1201/9781315143873-16.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Koegel, Lynn Kern, Kristen Ashbaugh, and Robert L. Koegel. "Pivotal Response Treatment." In Evidence-Based Practices in Behavioral Health. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-30925-5_4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Treatment responder"

1

Furrer, Coline, Trisha I. Valerio, Sophia-Joy X. Patrock, et al. "Nano-ablative immunotherapy for the treatment of pancreatic cancer." In Biophotonics and Immune Responses XX, edited by Wei R. Chen and Feifan Zhou. SPIE, 2025. https://doi.org/10.1117/12.3043426.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Valerio, Trisha I., Coline Furrer, Jacob Adams, et al. "Optimization of localized ablative immunotherapy for pancreatic cancer treatment." In Biophotonics and Immune Responses XX, edited by Wei R. Chen and Feifan Zhou. SPIE, 2025. https://doi.org/10.1117/12.3044084.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Gric, Tatjana, and Edik U. Rafailov. "Metamaterial formalism approach towards precise choice of the antibiotic treatment." In Biophotonics and Immune Responses XX, edited by Wei R. Chen and Feifan Zhou. SPIE, 2025. https://doi.org/10.1117/12.3039807.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Saad, Mohammad A., Derek Allen, Nayab Tahir, et al. "Enhancing immune responses in pre-clinical oral cancer models through photodynamic priming using a low-cost imaging and treatment device." In Biophotonics and Immune Responses XX, edited by Wei R. Chen and Feifan Zhou. SPIE, 2025. https://doi.org/10.1117/12.3044068.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Roth, Michael D., Chi-Hong Tseng, Philip J. Clements, et al. "Predicting Treatment Outcomes And Responder Subsets In Scleroderma-Related Interstitial Lung Disease." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3822.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Vervoort, V., J. Vriezekolk, and C. van den Ende. "OP0344-HPR Development of responder criteria for multicomponent non-pharmacological treatment in fibromyalgia." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.3629.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Chandrasekaran, Ramya, Darbie Whitman, Ray Fox, Tom Graddis, and Kamal Puri. "39 Interrogating elite responder humoral responses to identify novel targets and therapeutic antibodies for the treatment of cancer." In SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.0039.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Yoshii, I. "AB0997 Clinical characteristics of non-responder to denosumab treatment for postmenopausal osteoporosis in japanese woman." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.1263.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Signorelli, Diego, Michele Del Vecchio, Marina Garassino, et al. "Abstract A018: Onset of dysthyroidism during treatment with immune checkpoint inhibitors is increased in responder patients." In Abstracts: CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival; September 16-19, 2015; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr15-a018.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Ashina, Messoud, Richard B. Lipton, Jessica Ailani, et al. "Responder Rates With Eptinezumab Over 24 Weeks in Patients With Prior Migraine Preventive Treatment Failures (S47.007)." In 2023 Annual Meeting Abstracts. Lippincott Williams & Wilkins, 2023. http://dx.doi.org/10.1212/wnl.0000000000203094.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Treatment responder"

1

Yu, Winifred, Elise Digga, Courtney Luterbach, et al. Association Between Outcomes and Dental Services in People Receiving Treatments That Cause Medication-Related Osteonecrosis of the Jaw: A Rapid Response Review. AHRQ, 2025. https://doi.org/10.23970/ahrqepc_rapid_dental_jaw.

Повний текст джерела
Анотація:
This review is undertaken to answer the following questions: Key Question 1: What is the effectiveness of dental services in improving health outcomes in people receiving treatments that cause medication-related osteonecrosis of the jaw (MRONJ) before, during, or after treatment with bisphosphonates, antiangiogenics, and other drugs for conditions other than cancer? Key Question 2: What are the clinical practice guidelines or standards for dental care for people receiving treatments that cause MRONJ? Key Messages: The body of evidence informing KQ1 consists of two randomized clinical trials (R
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Bray, Elizabeth, Zvi Lerner, and Alexander Poljakoff-Mayber. The Role of Phytohormones in the Response of Plants to Salinity Stress. United States Department of Agriculture, 1994. http://dx.doi.org/10.32747/1994.7613007.bard.

Повний текст джерела
Анотація:
Salinity is an increasing problem in many irrigated areas of crop production and is a significant factor in reducing crop productivity. Developmental, physiological, and molecular responses to salinity were studied in order to improve our understanding of these responses. Improvements in our understanding of plant responses to salinity are necessary in order to develop crops with improved salt tolerance. Previously, in Israel, it was shown that Sorghum biccolor can adapt to an otherwise lethal concentration of NaCl. These experiments were refined and it was shown that there is a specific windo
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Schad, Aaron, Gary Dick, Kris Erickson, Paul Fuhrmann, and Lynde Dodd. Vegetation community changes in response to phragmites management at Times Beach, Buffalo, New York. Engineer Research and Development Center (U.S.), 2021. http://dx.doi.org/10.21079/11681/42149.

Повний текст джерела
Анотація:
Management of invasive phragmites (Phragmites australis [Cav.] Trin. Ex Steud.) in the United States has proven challenging over the last several decades. Various methods for control exist, but integrated approaches appear to have the most success. However, documentation of vegetation community–wide responses to these approaches remains limited. This study monitored plant community changes at Times Beach, New York, over a five-year period. In concert with mowing and thatch removal in all areas, the study evaluated two herbicides separately and together, representing three experimental treatmen
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Manski, Charles. Using Studies of Treatment Response to Inform Treatment Choice in Heterogeneous Populations. National Bureau of Economic Research, 2000. http://dx.doi.org/10.3386/t0263.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Angrist, Joshua, and Guido Imbens. Average Causal Response with Variable Treatment Intensity. National Bureau of Economic Research, 1995. http://dx.doi.org/10.3386/t0127.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Manski, Charles F. Identification of treatment response with social interactions. Institute for Fiscal Studies, 2010. http://dx.doi.org/10.1920/wp.cem.2010.0110.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Pokrzywinski, Kaytee, West Bishop, Christopher Grasso, Kaitlin Volk, and Kurt Getsinger. Chemical management strategies for starry stonewort : a mesocosm study. Engineer Research and Development Center (U.S.), 2021. http://dx.doi.org/10.21079/11681/42040.

Повний текст джерела
Анотація:
US Environmental Protection Agency (USEPA) approved algaecides and herbicides are frequently utilized to manage nuisance algae and aquatic macrophytes. However, there is limited information available on the effectiveness of these products for the management of starry stonewort. Thus, the goal of this research was to discern effective chemical control products for later growth stages of starry stonewort using mesocosm studies. Eleven treatments were evaluated using various combinations of four copper-based products, endothall, diquat, and carfentrazone – all with USEPA registrations for use in
Стилі APA, Harvard, Vancouver, ISO та ін.
8

DeJong, Joel L., and David Haden. Soybean Yield Response to Late Soybean Aphid Treatment. Iowa State University, Digital Repository, 2004. http://dx.doi.org/10.31274/farmprogressreports-180814-661.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Patricia van Es, Nina. Illness and the Treatment Response: The Patient's View. Portland State University Library, 2000. http://dx.doi.org/10.15760/etd.6762.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Sartain, Bradley, Erika Haug, Kurt Getsinger, Benjamin Sperry, Mark Heilman, and Mike Greer. Small plot applications of florpyrauxifen–benzyl (Procellacor SC™) for control of monoecious hydrilla in Roanoke Rapids Lake, NC. Engineer Research and Development Center (U.S.), 2023. http://dx.doi.org/10.21079/11681/47115.

Повний текст джерела
Анотація:
Four demonstration plots were selected at Roanoke Rapids Lake, NC to evaluate water exchange and aqueous herbicide residues in stands of submersed aquatic vegetation (SAV) following treatment with rhodamine wt dye and florpyrauxifen-benzyl to control monecious hydrilla. Florpyrauxifen-benzyl (Procellacor™ SC) was applied in combination with Rhodamine WT (RWT) at two of the plots. Dye measurements and herbicide residue samples were collected at specific time intervals to draw comparisons between herbicide and RWT dye dissipation. The two additional plots served as reference plots to the treatme
Стилі APA, Harvard, Vancouver, ISO та ін.
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!